about
Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats.Cardiomyocyte marker expression in mouse embryonic fibroblasts by cell-free cardiomyocyte extract and epigenetic manipulation.Wharton's Jelly-derived Mesenchymal Stem Cells can Differentiate into Hepatocyte-like Cells by HepG2 Cell Line Extract.Cardiomyocyte marker expression in a human lymphocyte cell line using mouse cardiomyocyte extract.The effect of amniotic membrane extract on umbilical cord blood mesenchymal stem cell expansion: is there any need to save the amniotic membrane besides the umbilical cord blood?Comparison of hepatic nuclear factor-4 expression in two- and three-dimensional culture of Wharton's jelly-derived cells exposed to hepatogenic medium.An in vitro model for hepatocyte-like cell differentiation from Wharton's jelly derived-mesenchymal stem cells by cell-base aggregates.Comparison of the Expression of Hepatic Genes by Human Wharton's Jelly Mesenchymal Stem Cells Cultured in 2D and 3D Collagen Culture Systems.Expression of pluripotency markers in human granulosa cells after embryonic stem cell extract exposure and epigenetic modification.Quantitative study of the effects of morphine on the mouse spleen and inguinal lymph node.Hepatogenic Differentiation Capacity of Human Wharton's Jelly Mesenchymal Stem Cell in a Co-culturing System with Endothelial Cells in Matrigel/collagen Scaffold in the Presence of Fetal Liver Extract.The influence of fibroblast growth factor 4 on hepatogenic capacity of Wharton's jelly mesenchymal stromal cells.Toxic effects of Elaeagnus angustifolia fruit extract on chondrogenesis and osteogenesis in mouse limb buds.Fabrication and characterization of platelet-rich plasma scaffolds for tissue engineering applications.Effects of platelet-rich plasma on liver regeneration in CCl4-induced hepatotoxicity model.Decellularized human ovarian scaffold based on a sodium lauryl ester sulfate (SLES)-treated protocol, as a natural three-dimensional scaffold for construction of bioengineered ovaries
P50
Q36292791-FFE64A2C-EFFA-4845-9A80-71090ECBE908Q38846109-424363F1-2E70-454D-922D-15AD7B82E078Q38893372-41648657-C248-4472-922D-621A41C38468Q39547167-4DFB3904-ADDB-4F20-AEFC-042CEEB0C7D0Q39939439-216E6891-B8EA-4B6F-9F88-C7A5C3588D17Q40131174-BD690139-F34B-44BC-AE40-9DB15095BF18Q42579826-9AEFF030-FEC6-4494-8C5F-FCB3DFE10869Q42663786-EC993473-AAC2-4135-A3E8-A4C62581A417Q42882218-393A9EAE-9143-400A-B38A-C5E8C2763E89Q42992231-C635596B-B289-4FD7-B203-CE69AD6E6273Q47108586-6D683A3C-B912-4B4A-897E-1F1261445A99Q50237356-37F3DAA8-C6A1-46C8-A839-F88AC93D072AQ50271565-2310E1FD-7378-4DC7-87C5-46BE57404B0CQ51005311-E558DF1E-DE92-4FE5-86C6-AB6293E48C3DQ51306920-1720FA65-B1E6-4E0D-A01A-30589A15A572Q58695085-030EF646-C5DB-4A00-9364-772A8A515006
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Zahra Vojdani
@ast
Zahra Vojdani
@en
Zahra Vojdani
@es
Zahra Vojdani
@nl
type
label
Zahra Vojdani
@ast
Zahra Vojdani
@en
Zahra Vojdani
@es
Zahra Vojdani
@nl
prefLabel
Zahra Vojdani
@ast
Zahra Vojdani
@en
Zahra Vojdani
@es
Zahra Vojdani
@nl
P106
P1153
56078094900
P31
P496
0000-0001-8214-2309